JBT MAREL CORP (JBTM) Fundamental Analysis & Valuation

NYSE:JBTM • US4778391049

142.03 USD
+1.02 (+0.72%)
At close: Mar 11, 2026
142.03 USD
0 (0%)
After Hours: 3/11/2026, 8:05:24 PM

This JBTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall JBTM gets a fundamental rating of 4 out of 10. We evaluated JBTM against 131 industry peers in the Machinery industry. Both the profitability and financial health of JBTM have multiple concerns. JBTM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. JBTM Profitability Analysis

1.1 Basic Checks

  • In the past year JBTM was profitable.
  • In the past year JBTM had a positive cash flow from operations.
  • JBTM had positive earnings in 4 of the past 5 years.
  • JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • With a Return On Assets value of -0.62%, JBTM is not doing good in the industry: 69.47% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -1.13%, JBTM is doing worse than 66.41% of the companies in the same industry.
  • The Return On Invested Capital of JBTM (2.97%) is worse than 64.12% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is significantly below the industry average of 10.16%.
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROIC 2.97%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • The Operating Margin of JBTM (5.80%) is comparable to the rest of the industry.
  • JBTM's Operating Margin has declined in the last couple of years.
  • JBTM has a better Gross Margin (35.15%) than 64.12% of its industry peers.
  • JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.8%
PM (TTM) N/A
GM 35.15%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

2

2. JBTM Health Analysis

2.1 Basic Checks

  • JBTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, JBTM has more shares outstanding
  • JBTM has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for JBTM has been reduced compared to a year ago.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • JBTM has an Altman-Z score of 1.97. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of JBTM (1.97) is worse than 64.89% of its industry peers.
  • The Debt to FCF ratio of JBTM is 7.90, which is on the high side as it means it would take JBTM, 7.90 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.90, JBTM is in line with its industry, outperforming 46.56% of the companies in the same industry.
  • JBTM has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • JBTM has a Debt to Equity ratio of 0.33. This is in the better half of the industry: JBTM outperforms 62.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Altman-Z 1.97
ROIC/WACC0.32
WACC9.3%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that JBTM may have some problems paying its short term obligations.
  • JBTM's Current ratio of 0.98 is on the low side compared to the rest of the industry. JBTM is outperformed by 87.02% of its industry peers.
  • A Quick Ratio of 0.58 indicates that JBTM may have some problems paying its short term obligations.
  • JBTM has a worse Quick ratio (0.58) than 87.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.58
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. JBTM Growth Analysis

3.1 Past

  • JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.10%, which is quite impressive.
  • JBTM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.06% yearly.
  • JBTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 121.34%.
  • Measured over the past years, JBTM shows a quite strong growth in Revenue. The Revenue has been growing by 17.06% on average per year.
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%

3.2 Future

  • Based on estimates for the next years, JBTM will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.54% on average per year.
  • The Revenue is expected to grow by 5.56% on average over the next years.
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. JBTM Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.26, JBTM is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of JBTM indicates a somewhat cheap valuation: JBTM is cheaper than 64.89% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.15, JBTM is valued at the same level.
  • JBTM is valuated correctly with a Price/Forward Earnings ratio of 16.95.
  • Based on the Price/Forward Earnings ratio, JBTM is valued a bit cheaper than the industry average as 74.05% of the companies are valued more expensively.
  • JBTM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 22.26
Fwd PE 16.95
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • JBTM's Enterprise Value to EBITDA ratio is in line with the industry average.
  • JBTM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 31
EV/EBITDA 18.59
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • JBTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JBTM's earnings are expected to grow with 18.54% in the coming years.
PEG (NY)0.71
PEG (5Y)2.21
EPS Next 2Y22.03%
EPS Next 3Y18.54%

3

5. JBTM Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.26%, JBTM is not a good candidate for dividend investing.
  • JBTM's Dividend Yield is comparable with the industry average which is at 1.13.
  • Compared to an average S&P500 Dividend Yield of 1.82, JBTM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.26%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 4.31%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
  • The dividend of JBTM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-41.39%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

JBTM Fundamentals: All Metrics, Ratios and Statistics

JBT MAREL CORP

NYSE:JBTM (3/11/2026, 8:05:24 PM)

After market: 142.03 0 (0%)

142.03

+1.02 (+0.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners100.27%
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner Change-1.34%
Market Cap7.38B
Revenue(TTM)3.80B
Net Income(TTM)-50.50M
Analysts83.33
Price Target159.94 (12.61%)
Short Float %4.99%
Short Ratio5.06
Dividend
Industry RankSector Rank
Dividend Yield 0.26%
Yearly Dividend0.5
Dividend Growth(5Y)4.31%
DP-41.39%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.53%
Min EPS beat(2)0.65%
Max EPS beat(2)26.4%
EPS beat(4)4
Avg EPS beat(4)13.8%
Min EPS beat(4)0.65%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.07%
EPS beat(12)9
Avg EPS beat(12)5.79%
EPS beat(16)12
Avg EPS beat(16)7.67%
Revenue beat(2)1
Avg Revenue beat(2)2.41%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.3%
Revenue beat(12)4
Avg Revenue beat(12)-4.47%
Revenue beat(16)5
Avg Revenue beat(16)-3.58%
PT rev (1m)0%
PT rev (3m)3.98%
EPS NQ rev (1m)-2.18%
EPS NQ rev (3m)-1.97%
EPS NY rev (1m)6.27%
EPS NY rev (3m)6.32%
Revenue NQ rev (1m)2.1%
Revenue NQ rev (3m)2.21%
Revenue NY rev (1m)2.19%
Revenue NY rev (3m)2.27%
Valuation
Industry RankSector Rank
PE 22.26
Fwd PE 16.95
P/S 1.94
P/FCF 31
P/OCF 21.6
P/B 1.65
P/tB N/A
EV/EBITDA 18.59
EPS(TTM)6.38
EY4.49%
EPS(NY)8.38
Fwd EY5.9%
FCF(TTM)4.58
FCFY3.23%
OCF(TTM)6.57
OCFY4.63%
SpS73.08
BVpS85.89
TBVpS-20.91
PEG (NY)0.71
PEG (5Y)2.21
Graham Number111.04
Profitability
Industry RankSector Rank
ROA -0.62%
ROE -1.13%
ROCE 3.35%
ROIC 2.97%
ROICexc 3.05%
ROICexgc 22.87%
OM 5.8%
PM (TTM) N/A
GM 35.15%
FCFM 6.27%
ROA(3y)7.79%
ROA(5y)6.83%
ROE(3y)14.51%
ROE(5y)14.91%
ROIC(3y)4.56%
ROIC(5y)5.43%
ROICexc(3y)6.15%
ROICexc(5y)6.51%
ROICexgc(3y)26.08%
ROICexgc(5y)24.27%
ROCE(3y)5.13%
ROCE(5y)6.12%
ROICexgc growth 3Y6.06%
ROICexgc growth 5Y-7.67%
ROICexc growth 3Y-21.96%
ROICexc growth 5Y-23.95%
OM growth 3Y-13.13%
OM growth 5Y-10.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.82%
GM growth 5Y2.73%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 7.9
Debt/EBITDA 3.02
Cap/Depr 38.92%
Cap/Sales 2.73%
Interest Coverage 250
Cash Conversion 70.25%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.58
Altman-Z 1.97
F-Score3
WACC9.3%
ROIC/WACC0.32
Cap/Depr(3y)47.22%
Cap/Depr(5y)64.88%
Cap/Sales(3y)2.75%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.1%
EPS 3Y10.26%
EPS 5Y10.06%
EPS Q2Q%16.47%
EPS Next Y31.31%
EPS Next 2Y22.03%
EPS Next 3Y18.54%
EPS Next 5YN/A
Revenue 1Y (TTM)121.34%
Revenue growth 3Y33.67%
Revenue growth 5Y17.06%
Sales Q2Q%115.57%
Revenue Next Year6.73%
Revenue Next 2Y5.73%
Revenue Next 3Y5.56%
Revenue Next 5YN/A
EBIT growth 1Y83.81%
EBIT growth 3Y16.11%
EBIT growth 5Y4.61%
EBIT Next Year75.71%
EBIT Next 3Y29.74%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3Y60.4%
FCF growth 5Y1.81%
OCF growth 1Y46.28%
OCF growth 3Y33.91%
OCF growth 5Y6.28%

JBT MAREL CORP / JBTM FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 4 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 4 / 10 to JBT MAREL CORP (JBTM). This can be considered as Fairly Valued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -41.39%.